Every material Form 8-K Medical Properties Trust filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Medical Properties Trust reported a third quarter 2024 net loss attributable to common stockholders of $801 million, or $1.34 per share, versus net income of $117 million, or $0.19 per share, a year earlier. The loss reflects about $608 million of impairment charges, largely tied to Steward hospitals, while normalized funds from operations (NFFO) fell to $94 million, or $0.16 per share, from $226 million, or $0.38 per share.
Q3 2024 net loss of $801 million ($1.34 per share) vs. net income of $117 million ($0.19 per share) in Q3 2023
NFFO of $94 million ($0.16 per share) vs. $226 million ($0.38 per share) a year earlier
$425 million impairment of Steward working capital loans and $134 million reduction in the fair value of the PHP Holdings investment
Sold 18 freestanding emergency department facilities and one general acute hospital in Arizona and Colorado for about $246 million
Medical Properties Trust said a global settlement with Steward Health Care, approved on an interim basis by the bankruptcy court on September 11, 2024, terminated its master lease with Steward and ends its business relationship and investments in Steward affiliates once completed. The company expects new third-quarter 2024 charges, including about $430 million of impairments and about $120 million of amortization expense, following $470 million of impairments in the first quarter and $490 million in the second quarter. The filing also says more impairments are possible, particularly on vacant properties previously leased to Steward.
Master Lease I was deemed terminated, and 15 leased hospitals moved to new interim managers effective September 11, 2024; permanent transfers are targeted by October 1, 2024.
Expected third-quarter 2024 impairment of about $430 million on working capital and secured loans, plus a Space Coast Facilities real estate charge of $100 million to $200 million.
Expected about $120 million of amortization expense in the third quarter 2024 to fully amortize the terminated lease's intangibles.
Cash rent is not due for the rest of 2024 on the 15 properties; the company agreed to loans of up to about $80 million to the new operators.
Medical Properties Trust reported a second-quarter 2024 net loss of $321 million, or $0.54 per share, compared with a net loss of $42 million, or $0.07 per share, a year earlier. Normalized FFO fell to $139 million, or $0.23 per share, from $285 million, or $0.48 per share. The company also amended its credit agreement, which cuts the revolver to $1.28 billion and limits cash dividends to $0.08 per share per quarter through September 30, 2025.
Q2 net loss of $321 million ($0.54 per share) versus $42 million ($0.07 per share) a year earlier, including about $400 million in real estate gains and about $700 million in impairments and negative fair value adjustments
Normalized FFO of $139 million ($0.23 per share) versus $285 million ($0.48 per share) in the year-earlier quarter
Credit amendment dated August 6, 2024 cuts revolving commitments from $1.4 billion to $1.28 billion and limits cash dividends to $0.08 per share per quarter through September 30, 2025
Maximum total leverage ratio raised from 60% to 65%; minimum unsecured interest coverage ratio lowered from 1.75:1.00 to 1.45:1.00; borrowing spreads rise to 300 basis points during the covenant period
Medical Properties Trust received a New York Stock Exchange notice on May 16, 2024, because it has not yet filed its Form 10-Q for the period ended March 31, 2024. The company attributes the delay to added impairment reviews after tenant Steward Health Care System filed for voluntary bankruptcy, and says the notice has no immediate effect on its listing. Shareholders face the risk that the NYSE could start delisting procedures if the filing is not completed within the allowed period.
The quarterly report was not filed by its prescribed due date, after Steward Health Care System's voluntary bankruptcy petition, filed four days before that date, required additional impairment procedures.
The NYSE notice, received May 16, 2024, cites non-compliance with Section 802.01E, which requires timely filing of periodic reports.
The company has six months from May 15, 2024 to regain compliance, with a possible additional six-month extension at the NYSE's discretion.
PricewaterhouseCoopers LLP needs more time to complete its interim review, and the NYSE may begin delisting procedures earlier if it deems circumstances warrant.
Medical Properties Trust recorded about $470 million of additional impairment charges in the quarter ended March 31, 2024, after Steward Health Care System filed for Chapter 11 bankruptcy on May 6, 2024. The charges fully reserve its 9.9% equity stake in Steward and a $362 million loan to Steward affiliates, and the company said it cannot yet estimate the cash costs of pursuing recovery.
About $470 million of additional impairment charges recorded in the quarter ended March 31, 2024
The charges fully reserve the 9.9% equity interest in Steward and the $362 million loan due from Steward affiliates
The company believes its $346 million of non-real estate loans to Steward are fully recoverable based on an updated collateral analysis
Steward leases 28 facilities under a master lease totaling about $2.4 billion; the company cannot estimate future recovery costs and warns of possible further impairments
Medical Properties Trust reported a first-quarter net loss of $736 million ($1.23 per share), compared with net income of $33 million a year earlier, driven by $693 million in impairments tied mainly to Steward Health Care. Normalized FFO fell to $142 million ($0.24 per share) from $222 million ($0.37), and the company approved $75 million in debtor-in-possession financing after Steward filed for Chapter 11, which matters to shareholders given the sharp drop in earnings and the impairment charges.
Net loss of $736 million ($1.23 per share) vs. net income of $33 million ($0.05 per share) a year earlier; impairments of $693 million included a full reserve on an approximately $360 million Steward loan.
Normalized FFO of $142 million ($0.24 per share) vs. $222 million ($0.37) a year earlier, primarily due to a significant decrease in Steward-related revenue.
MPT approved $75 million in debtor-in-possession financing for Steward after its Chapter 11 filing; the financing is subject to bankruptcy court approval.
Executed $1.6 billion in year-to-date liquidity transactions, 80% of the initial 2024 target, and now expects to exceed the $2.0 billion target.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Medical Properties Trust filing is on SEC EDGAR ↗. 8-K briefs of other companies →